PE20060485A1 - Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits - Google Patents
Regimenes anticonceptivos con antagonistas del receptor de progesterona y kitsInfo
- Publication number
- PE20060485A1 PE20060485A1 PE2005000782A PE2005000782A PE20060485A1 PE 20060485 A1 PE20060485 A1 PE 20060485A1 PE 2005000782 A PE2005000782 A PE 2005000782A PE 2005000782 A PE2005000782 A PE 2005000782A PE 20060485 A1 PE20060485 A1 PE 20060485A1
- Authority
- PE
- Peru
- Prior art keywords
- progesterone receptor
- chloro
- kits
- receptor antagonists
- contraceptive
- Prior art date
Links
- 239000003433 contraceptive agent Substances 0.000 title abstract 2
- 230000002254 contraceptive effect Effects 0.000 title abstract 2
- 229940123788 Progesterone receptor antagonist Drugs 0.000 title 1
- 102000003998 progesterone receptors Human genes 0.000 abstract 3
- 108090000468 progesterone receptors Proteins 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 2
- IEXUMDBQLIVNHZ-YOUGDJEHSA-N (8s,11r,13r,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)CCCO)[C@@]2(C)C1 IEXUMDBQLIVNHZ-YOUGDJEHSA-N 0.000 abstract 1
- RCOWGILQXUPXEW-FUSOFXSQSA-N (8s,11r,13s,14s,17r)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-[(z)-3-hydroxyprop-1-enyl]-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@@]2(O)\C=C/CO)[C@]2(C)C1 RCOWGILQXUPXEW-FUSOFXSQSA-N 0.000 abstract 1
- XFMKDGCFYDJTBW-UHFFFAOYSA-N 1,3-dihydroindol-2-one 1H-indole Chemical compound C1=CC=C2NC=CC2=C1.C1=CC=C2NC(=O)CC2=C1 XFMKDGCFYDJTBW-UHFFFAOYSA-N 0.000 abstract 1
- -1 ASOPRISINIL Chemical compound 0.000 abstract 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229950001701 lilopristone Drugs 0.000 abstract 1
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 abstract 1
- 229960003248 mifepristone Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229950011093 onapristone Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000902 placebo Substances 0.000 abstract 1
- 229940068196 placebo Drugs 0.000 abstract 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA ANTICONCEPTIVA, QUE COMPRENDE UN ANTAGONISTA DEL RECEPTOR DE PROGESTERONA (RP), SELECCIONADO DE MIFEPRISTONA, ONAPRISTONA, LILOPRISTONA, ASOPRISINIL, CDB-2914, 3-CLORO-5-(4,4-DIMETIL-2-OXO-1,4-DIHIDRO-2H-BENZO[d][1,3]OXAZIN-6-IL)-BENZONITRILO O UN COMPUESTO DERIVADO DE INDOL-OXINDOL, ENTRE OTROS; EN EL CUAL DICHA COMPOSICION SE ADMINISTRA DURANTE 28 DIAS CONSECUTIVOS, DE ACUERDO CON LOS PASOS: a) UNA PRIMERA FASE DE 21 A 27 UNIDADES DE DOSIFICACION DIARIA DEL ANTAGONISTA DE RP; Y b) UNA SEGUNDA FASE DE 1 A 7 UNIDADES DE DOSIFICACION DIARIAS DE UN PLACEBO FARMACEUTICAMENTE ACEPTABLE. ADEMAS SE REFIERE A UN KIT QUE COMPRNDE DICHAS UNIDADES DE DOSIFICACION
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58588304P | 2004-07-07 | 2004-07-07 | |
| US67613505P | 2005-04-29 | 2005-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060485A1 true PE20060485A1 (es) | 2006-06-24 |
Family
ID=35106665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000782A PE20060485A1 (es) | 2004-07-07 | 2005-07-06 | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060009509A1 (es) |
| EP (1) | EP1773323A1 (es) |
| JP (1) | JP2008505906A (es) |
| KR (1) | KR20070039912A (es) |
| AR (1) | AR049664A1 (es) |
| AU (1) | AU2005271974A1 (es) |
| BR (1) | BRPI0512993A (es) |
| CA (1) | CA2571198A1 (es) |
| CR (1) | CR8800A (es) |
| EC (1) | ECSP077131A (es) |
| GT (1) | GT200500186A (es) |
| IL (1) | IL180238A0 (es) |
| MX (1) | MXPA06014580A (es) |
| NO (1) | NO20070377L (es) |
| PA (1) | PA8638501A1 (es) |
| PE (1) | PE20060485A1 (es) |
| RU (1) | RU2006144069A (es) |
| SV (1) | SV2006002166A (es) |
| TW (1) | TW200605880A (es) |
| WO (1) | WO2006017075A1 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| GB0121285D0 (en) * | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| CN1980676A (zh) | 2004-07-07 | 2007-06-13 | 惠氏公司 | 周期性黄体酮方案及试剂盒 |
| US8865200B2 (en) | 2004-07-09 | 2014-10-21 | Laboratoire Hra Pharma | Sustained release compositions containing progesterone receptor modulators |
| GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
| MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| CN101631546A (zh) | 2006-10-12 | 2010-01-20 | 泽农医药公司 | 螺-吲哚酮化合物作为治疗剂的用途 |
| CA2741024A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| AU2009303468B2 (en) | 2008-10-17 | 2014-08-28 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| EP2419108B1 (en) | 2009-04-14 | 2016-08-17 | Laboratoire HRA Pharma | Method for on-demand contraception |
| BRPI1011784A2 (pt) | 2009-06-18 | 2016-03-22 | Pfizer | compostos bicíclicos e tricíclicos como inibidores de kat ii |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| NZ599334A (en) | 2009-10-14 | 2014-03-28 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
| MY165117A (en) | 2010-02-26 | 2018-02-28 | Xenon Pharmaceuticals Inc | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| US9375437B2 (en) | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
| KR101544290B1 (ko) | 2010-12-01 | 2015-08-12 | 화이자 인코포레이티드 | Kat ii 억제제 |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| JP2016510791A (ja) | 2013-03-14 | 2016-04-11 | ラボラトワール・アシュエールア−ファルマＬａｂｏｒａｔｏｉｒｅ Ｈｒａ−Ｐｈａｒｍａ | 排卵の予定を決める方法 |
| TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
| JP2018522854A (ja) | 2015-06-22 | 2018-08-16 | リポカイン インコーポレーテッド | １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6444668B1 (en) * | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
| US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
-
2005
- 2005-07-04 GT GT200500186A patent/GT200500186A/es unknown
- 2005-07-06 US US11/175,549 patent/US20060009509A1/en not_active Abandoned
- 2005-07-06 AR ARP050102807A patent/AR049664A1/es unknown
- 2005-07-06 PE PE2005000782A patent/PE20060485A1/es not_active Application Discontinuation
- 2005-07-06 RU RU2006144069/15A patent/RU2006144069A/ru not_active Application Discontinuation
- 2005-07-06 TW TW094122826A patent/TW200605880A/zh unknown
- 2005-07-06 JP JP2007520434A patent/JP2008505906A/ja active Pending
- 2005-07-06 SV SV2005002166A patent/SV2006002166A/es not_active Application Discontinuation
- 2005-07-06 PA PA20058638501A patent/PA8638501A1/es unknown
- 2005-07-06 BR BRPI0512993-1A patent/BRPI0512993A/pt not_active Application Discontinuation
- 2005-07-06 EP EP05771038A patent/EP1773323A1/en not_active Withdrawn
- 2005-07-06 KR KR1020077000184A patent/KR20070039912A/ko not_active Withdrawn
- 2005-07-06 MX MXPA06014580A patent/MXPA06014580A/es unknown
- 2005-07-06 CA CA002571198A patent/CA2571198A1/en not_active Abandoned
- 2005-07-06 WO PCT/US2005/023798 patent/WO2006017075A1/en not_active Ceased
- 2005-07-06 AU AU2005271974A patent/AU2005271974A1/en not_active Abandoned
-
2006
- 2006-12-07 CR CR8800A patent/CR8800A/es not_active Application Discontinuation
- 2006-12-21 IL IL180238A patent/IL180238A0/en unknown
-
2007
- 2007-01-05 EC EC2007007131A patent/ECSP077131A/es unknown
- 2007-01-19 NO NO20070377A patent/NO20070377L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CR8800A (es) | 2007-08-28 |
| SV2006002166A (es) | 2006-05-09 |
| AR049664A1 (es) | 2006-08-23 |
| TW200605880A (en) | 2006-02-16 |
| US20060009509A1 (en) | 2006-01-12 |
| MXPA06014580A (es) | 2007-03-23 |
| WO2006017075A1 (en) | 2006-02-16 |
| CA2571198A1 (en) | 2006-02-16 |
| BRPI0512993A (pt) | 2008-04-22 |
| ECSP077131A (es) | 2007-02-28 |
| KR20070039912A (ko) | 2007-04-13 |
| IL180238A0 (en) | 2007-07-04 |
| JP2008505906A (ja) | 2008-02-28 |
| PA8638501A1 (es) | 2006-07-03 |
| RU2006144069A (ru) | 2008-08-20 |
| GT200500186A (es) | 2006-03-02 |
| EP1773323A1 (en) | 2007-04-18 |
| AU2005271974A1 (en) | 2006-02-16 |
| NO20070377L (no) | 2007-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20060485A1 (es) | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
| EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| EA200600964A1 (ru) | Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина | |
| IL154988A0 (en) | Pharmaceutical compositions containing a 5-ht3 receptor antagonist | |
| PE20060378A1 (es) | Regimenes y kits de progestina ciclica | |
| BRPI0514180A (pt) | composto, composição farmacêutica, uso de um composto, kit farmaceuticamente útil adaptado para administração oral diária, e, métodos de preparação de um composto, e de contracepção em um mamìfero | |
| RU2007101304A (ru) | Модуляторы рецептора прогестерона, содержащие производные пиррол-оксиндола и применение | |
| HUP0301892A2 (hu) | Szexuális zavarok kezelésére szolgáló gyógyszerkészítmények és előállításuk | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
| PE20060275A1 (es) | Composicion farmaceutica que contiene progestina y estrogeno para el tratamiento de trastorno disforico premenstrual | |
| SG152257A1 (en) | Topical preparation containing ambroxol | |
| HUP0203148A2 (hu) | Mirtazapint tartalmazó orálisan dezintegrálódó készítmény | |
| DE60301261D1 (de) | Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist | |
| PE20040670A1 (es) | Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida | |
| NO20072893L (no) | Fast, peroralt prevensjonsmiddel | |
| AR044450A1 (es) | Composicion que comprende antagonistas de receptores de progesterona y antiestrogenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas | |
| CY1111406T1 (el) | Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης | |
| TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar | |
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| ES2136198T3 (es) | Composiciones rectales que contienen odansetron en forma de su base libre. | |
| BRPI0302736B8 (pt) | composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual | |
| EA200600120A1 (ru) | ЧИСТЫЕ ИЗОМЕРЫ d-(17α)-13-ЭТИЛ-17-ГИДРОКСИ-18,19-ДИНОРПРЕГН-4-ЕН-20-ИН-3-ОН-3E И 3Z-ОКСИМОВ, СПОСОБ СИНТЕЗА СМЕСИ ИЗОМЕРОВ И ЧИСТЫХ ИЗОМЕРОВ | |
| PE20000887A1 (es) | Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |